The Legionella pneumophila effector SidL is an adenylyltransferase that modifies the glycolytic intermediate 3-phosphoglycerate.

Saved in:
Bibliographic Details
Title: The Legionella pneumophila effector SidL is an adenylyltransferase that modifies the glycolytic intermediate 3-phosphoglycerate.
Authors: Black JJ; Department of Molecular Biology & Genetics, Johns Hopkins University School of Medicine, Baltimore, MD, USA; Howard Hughes Medical Institute, Chevy Chase, MD, USA., Burroughs AM; Computational Biology Branch, Division of Intramural Research, National Library of Medicine, National Institutes of Health, Bethesda, MD, USA., Rashan EH; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, USA., Nosal CR; Department of Pharmacology and Molecular Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA; Chemistry-Biology Interface Graduate Training Program, Johns Hopkins University, Baltimore, MD, USA., Romanov KA; Department of Molecular Biology & Genetics, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Catipovic MA; Department of Molecular Biology & Genetics, Johns Hopkins University School of Medicine, Baltimore, MD, USA; Howard Hughes Medical Institute, Chevy Chase, MD, USA., Valadez C; Department of Molecular Biology & Genetics, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Aravind L; Computational Biology Branch, Division of Intramural Research, National Library of Medicine, National Institutes of Health, Bethesda, MD, USA., Hicks KG; Department of Nutrition & Integrative Physiology, University of Utah College of Health, Salt Lake City, UT, USA., Freel Meyers CL; Department of Pharmacology and Molecular Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA; Chemistry-Biology Interface Graduate Training Program, Johns Hopkins University, Baltimore, MD, USA., O'Connor TJ; Department of Molecular Biology & Genetics, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Vander Heiden MG; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, USA; Dana-Farber Cancer Institute, Boston, MA, USA., Green R; Department of Molecular Biology & Genetics, Johns Hopkins University School of Medicine, Baltimore, MD, USA; Howard Hughes Medical Institute, Chevy Chase, MD, USA. Electronic address: ragreen@jhmi.edu.
Source: Molecular cell [Mol Cell] 2026 Jul 24. Date of Electronic Publication: 2026 Jul 24.
Publication Type: Journal Article
Journal Info: Publisher: Cell Press Country of Publication: United States NLM ID: 9802571 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-4164 (Electronic) Linking ISSN: 10972765 NLM ISO Abbreviation: Mol Cell Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1097-4164
DOI:10.1016/j.molcel.2026.07.007